These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19747133)

  • 21. Dawn of non-nucleoside inhibitor-based anti-HIV microbicides.
    D'Cruz OJ; Uckun FM
    J Antimicrob Chemother; 2006 Mar; 57(3):411-23. PubMed ID: 16431862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural Modifications of Diarylpyrimidine-quinolone Hybrids as Potent HIV-1 NNRTIs with an Improved Drug Resistance Profile.
    Mao TQ; He QQ; Chen WX; Tang GF; Chen FE; De Clercq E; Daelemans D; Pannecouque C
    Curr Pharm Des; 2016; 22(46):6982-6987. PubMed ID: 27875973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Discovery and development of diarylpyrimidines (DAPYs) as next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs)].
    Tian XT; Xie L
    Yao Xue Xue Bao; 2010 Feb; 45(2):177-83. PubMed ID: 21351427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies.
    Chen R; Yokoyama M; Sato H; Reilly C; Mansky LM
    J Virol; 2005 Sep; 79(18):12045-57. PubMed ID: 16140780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored "hydrophobic channel".
    Zhou Z; Liu T; Kang D; Huo Z; Wu G; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
    Org Biomol Chem; 2018 Feb; 16(6):1014-1028. PubMed ID: 29349445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
    J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in the DABOs family as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Yu M; Fan E; Wu J; Liu X
    Curr Med Chem; 2011; 18(16):2376-85. PubMed ID: 21568919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel indazole non-nucleoside reverse transcriptase inhibitors using molecular hybridization based on crystallographic overlays.
    Jones LH; Allan G; Barba O; Burt C; Corbau R; Dupont T; Knöchel T; Irving S; Middleton DS; Mowbray CE; Perros M; Ringrose H; Swain NA; Webster R; Westby M; Phillips C
    J Med Chem; 2009 Feb; 52(4):1219-23. PubMed ID: 19175319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-Based Optimization of 2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Exploiting the Tolerant Regions of the Non-Nucleoside Reverse Transcriptase Inhibitors' Binding Pocket.
    Zhao F; Zhang H; Xie M; Meng B; Liu N; Dun C; Qin Y; Gao S; De Clercq E; Pannecouque C; Tang YJ; Zhan P; Liu X; Kang D
    J Med Chem; 2023 Feb; 66(3):2102-2115. PubMed ID: 36700940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-enhanced methods in the development of non-nucleoside inhibitors targeting HIV reverse transcriptase variants.
    Frey KM
    Future Microbiol; 2015; 10(11):1767-72. PubMed ID: 26517310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural insights into mechanisms of non-nucleoside drug resistance for HIV-1 reverse transcriptases mutated at codons 101 or 138.
    Ren J; Nichols CE; Stamp A; Chamberlain PP; Ferris R; Weaver KL; Short SA; Stammers DK
    FEBS J; 2006 Aug; 273(16):3850-60. PubMed ID: 16911530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel molecular mechanism of dual resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors.
    Nikolenko GN; Delviks-Frankenberry KA; Pathak VK
    J Virol; 2010 May; 84(10):5238-49. PubMed ID: 20219933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of NNRTIs on HIV reverse transcriptase dimerization.
    Tachedjian G; Goff SP
    Curr Opin Investig Drugs; 2003 Aug; 4(8):966-73. PubMed ID: 14508881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and evaluation of "dual-site"-binding diarylpyrimidines targeting both NNIBP and the NNRTI adjacent site of the HIV-1 reverse transcriptase.
    Feng D; Zuo X; Jing L; Chen CH; Olotu FA; Lin H; Soliman M; De Clercq E; Pannecouque C; Lee KH; Kang D; Liu X; Zhan P
    Eur J Med Chem; 2021 Feb; 211():113063. PubMed ID: 33340914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular insight on the binding of NNRTI to K103N mutated HIV-1 RT: molecular dynamics simulations and dynamic pharmacophore analysis.
    Nizami B; Sydow D; Wolber G; Honarparvar B
    Mol Biosyst; 2016 Oct; 12(11):3385-3395. PubMed ID: 27722739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mechanistic and structural investigation of modified derivatives of the diaryltriazine class of NNRTIs targeting HIV-1 reverse transcriptase.
    Mislak AC; Frey KM; Bollini M; Jorgensen WL; Anderson KS
    Biochim Biophys Acta; 2014 Jul; 1840(7):2203-11. PubMed ID: 24726448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 reverse transcriptase connection subdomain mutations involved in resistance to approved non-nucleoside inhibitors.
    Menéndez-Arias L; Betancor G; Matamoros T
    Antiviral Res; 2011 Nov; 92(2):139-49. PubMed ID: 21896288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The HEPT Analogue WPR-6 Is Active against a Broad Spectrum of Nonnucleoside Reverse Transcriptase Drug-Resistant HIV-1 Strains of Different Serotypes.
    Xu W; Zhao J; Sun J; Yin Q; Wang Y; Jiao Y; Liu J; Jiang S; Shao Y; Wang X; Ma L
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4882-8. PubMed ID: 26055365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hologram quantitative structure-activity relationships investigations of non-nucleoside reverse transcriptase inhibitors.
    Pungpo P; Hannongbua S; Wolschann P
    Curr Med Chem; 2003 Sep; 10(17):1661-77. PubMed ID: 12871115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097.
    Das K; Sarafianos SG; Clark AD; Boyer PL; Hughes SH; Arnold E
    J Mol Biol; 2007 Jan; 365(1):77-89. PubMed ID: 17056061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.